Acute coronary syndromes: 6c-Patients discharged on lipid-lowering therapy

Identifying and definitional attributes

Metadata item type:Indicator
Indicator type:Indicator
Short name:Indicator 6c-Patients discharged on lipid-lowering therapy
METeOR identifier:612087
Registration status:Health, Standard 12/09/2016

Proportion of patients with a final diagnosis of acute coronary syndrome (ACS) who are prescribed lipid-lowering therapy at separation from hospital.


Lowering lipid levels (using statins) is an effective primary and secondary prevention treatment for vascular events, including stroke (Amarenco et al. 2006).

Indicator set:Clinical care standard indicators: acute coronary syndromes Health, Standard 12/09/2016
Outcome area:Individualised care plan Health, Standard 12/09/2016

Collection and usage attributes

Computation description:

Both the numerator and the denominator include patients with acute chest pain, or other symptoms suggestive of ACS.

The denominator excludes statin-intolerant ACS patients, and other ACS patients for whom statins or other lipid-lowering therapies are contraindicated and for whom the contraindication is documented. Contraindications for statins may include advance care directives, being on a palliative care pathway, and clinical judgement, subject to discussion with patients, family and carers.

Presented as a percentage.


(Numerator ÷ denominator) x 100


Number of patients with a final diagnosis of ACS who are prescribed a statin or other lipid-lowering therapy at separation from hospital.


Number of patients with a final diagnosis of ACS who are separated from hospital.

Representational attributes

Representation class:Percentage
Data type:Real
Unit of measure:Episode


Source and reference attributes

Submitting organisation:

Australian Commission on Safety and Quality in Health Care

Reference documents:

Amarenco P et al. 2006. High-dose atorvastatin after stroke or transient ischemic attack. New England Journal of Medicine 355(6):549–559.